Adicet Bio (NASDAQ: ACET)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.100 | ||||||
REV | 24.990M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Adicet Bio (NASDAQ: ACET) through any online brokerage.
Other companies in Adicet Bio’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Cogent Biosciences (NASDAQ:COGT), Eagle Pharmaceuticals (NASDAQ:EGRX), Altimmune (NASDAQ:ALT) and Immatics (NASDAQ:IMTX).
The latest price target for Adicet Bio (NASDAQ: ACET) was reported by SMBC Nikko on Thursday, March 31, 2022. The analyst firm set a price target for 28.00 expecting ACET to rise to within 12 months (a possible 92.18% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Adicet Bio (NASDAQ: ACET) is $14.57 last updated Today at July 1, 2022, 4:03 PM UTC.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on October 9, 2018 to stockholders of record on September 21, 2018.
Adicet Bio’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Adicet Bio.
Adicet Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.